ANAPTYSBIO, INC

SEC 4 · Filed

0001477384-26-000005Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Apr 20, 2026

Grant, award or other acquisition by Orwin John A

Security
Stock Option (right to buy)
Code
A
Shares
8,250
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-04-20",
  "direction": "A",
  "exercise_price": "32.17",
  "expiration": "2036-01-06",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F3": "The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person\u0027s provision of service to the Issuer on each vesting date."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "8250",
  "price": "0",
  "row": 10,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "8250",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "8250"
}
Insider transactionsEvent date Apr 20, 2026

Disposition to issuer by Orwin John A

Security
Stock Option (right to buy)
Code
D
Shares
8,250
Price per share
0.00
Structured facts
{
  "code": "D",
  "date": "2026-04-20",
  "direction": "D",
  "exercise_price": "43.91",
  "expiration": "2035-01-06",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F3": "The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person\u0027s provision of service to the Issuer on each vesting date."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "8250",
  "price": "0",
  "row": 9,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "8250",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "8250"
}
Insider transactionsEvent date Apr 20, 2026

Grant, award or other acquisition by Orwin John A

Security
Stock Option (right to buy)
Code
A
Shares
16,510
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-04-20",
  "direction": "A",
  "exercise_price": "10.87",
  "expiration": "2035-01-06",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "16510",
  "price": "0",
  "row": 8,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "16510",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "16510"
}
Insider transactionsEvent date Apr 20, 2026

Disposition to issuer by Orwin John A

Security
Stock Option (right to buy)
Code
D
Shares
16,510
Price per share
0.00
Structured facts
{
  "code": "D",
  "date": "2026-04-20",
  "direction": "D",
  "exercise_price": "14.83",
  "expiration": "2035-01-06",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "16510",
  "price": "0",
  "row": 7,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "16510",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "16510"
}
Insider transactionsEvent date Apr 20, 2026

Grant, award or other acquisition by Orwin John A

Security
Stock Option (right to buy)
Code
A
Shares
16,510
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-04-20",
  "direction": "A",
  "exercise_price": "15.53",
  "expiration": "2034-01-02",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "16510",
  "price": "0",
  "row": 6,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "16510",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "16510"
}
Insider transactionsEvent date Apr 20, 2026

Disposition to issuer by Orwin John A

Security
Stock Option (right to buy)
Code
D
Shares
16,510
Price per share
0.00
Structured facts
{
  "code": "D",
  "date": "2026-04-20",
  "direction": "D",
  "exercise_price": "21.19",
  "expiration": "2034-01-02",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "16510",
  "price": "0",
  "row": 5,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "16510",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "16510"
}
Insider transactionsEvent date Apr 20, 2026

Grant, award or other acquisition by Orwin John A

Security
Stock Option (right to buy)
Code
A
Shares
10,600
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-04-20",
  "direction": "A",
  "exercise_price": "14.29",
  "expiration": "2033-09-14",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "10600",
  "price": "0",
  "row": 4,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "10600",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "10600"
}
Insider transactionsEvent date Apr 20, 2026

Disposition to issuer by Orwin John A

Security
Stock Option (right to buy)
Code
D
Shares
10,600
Price per share
0.00
Structured facts
{
  "code": "D",
  "date": "2026-04-20",
  "direction": "D",
  "exercise_price": "19.50",
  "expiration": "2033-09-14",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "10600",
  "price": "0",
  "row": 3,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "10600",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "10600"
}
Insider transactionsEvent date Apr 20, 2026

Grant, award or other acquisition by Orwin John A

Security
Stock Option (right to buy)
Code
A
Shares
3,311
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-04-20",
  "direction": "A",
  "exercise_price": "14.29",
  "expiration": "2033-09-14",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "3311",
  "price": "0",
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "3311",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "3311"
}
Insider transactionsEvent date Apr 20, 2026

Disposition to issuer by Orwin John A

Security
Stock Option (right to buy)
Code
D
Shares
3,311
Price per share
0.00
Structured facts
{
  "code": "D",
  "date": "2026-04-20",
  "direction": "D",
  "exercise_price": "19.50",
  "expiration": "2033-09-14",
  "footnotes": {
    "F1": "Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptysBio shares of common stock in an amount determined in accordance with the Separation Agreement.",
    "F2": "The stock option is fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001477384",
      "name": "Orwin John A",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "3311",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Stock Option (right to buy)",
  "shares": "3311",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "3311"
}